EMAIL THIS PAGE TO A FRIEND

Neuroscience letters

Functional evidence for involvement of bumetanide-sensitive Na+K+2CI- cotransport in the hepatoportal Na+ receptor of the Sprague-Dawley rat.


PMID 10320015

Abstract

To investigate mechanisms involved in hepatoportal Na+ sensing, responses of hepatic afferent nerve activity (HANA) to intraportal hypertonic NaCl injection were measured before, and after, intraportal infusion of inhibitors of Na+ transport systems. HANA increased in response to the intraportal injection of 0.75 M NaCl in a dose-dependent manner. The HANA response was not affected by amiloride or 4-acetamido-4'-isothiocyanato-stilbene-2,2'-disulfonic acid (SITS), but was suppressed in a dose-dependent manner by intraportal infusion of ouabain, furosemide, or bumetanide. These results indicate that the hepatoportal Na+ receptor senses the Na+ concentration via the bumetanide-sensitive Na+K+2Cl- cotransporter.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

B3023
Bumetanide, ≥98%
C17H20N2O5S